First Time Loading...

Regeneus Ltd
ASX:RGS

Watchlist Manager
Regeneus Ltd Logo
Regeneus Ltd
ASX:RGS
Watchlist
Price: 0.009 AUD Market Closed
Updated: May 6, 2024

Regeneus Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Regeneus Ltd
Net Income (Common) Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Regeneus Ltd
ASX:RGS
Net Income (Common)
-AU$2.8m
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
10%
Immutep Ltd
ASX:IMM
Net Income (Common)
-AU$40.5m
CAGR 3-Years
-14%
CAGR 5-Years
-19%
CAGR 10-Years
-12%
Mesoblast Ltd
ASX:MSB
Net Income (Common)
-$73.1m
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Net Income (Common)
$2.5B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
7%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Net Income (Common)
AU$30.2m
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Net Income (Common)
AU$5.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Regeneus Ltd's Net Income (Common)?
Net Income (Common)
-2.8m AUD

Based on the financial report for Dec 31, 2023, Regeneus Ltd's Net Income (Common) amounts to -2.8m AUD.

What is Regeneus Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
10%

Over the last year, the Net Income (Common) growth was 58%.